# Grace Therapeutics, Inc.: Form 8-K, filed Mar 31, 2023

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2023-03-31
- Accepted by EDGAR: Mar 31, 2023, 16:39 ET
- Period: 2023-03-30
- Accession: 0000950170-23-011424
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000095017023011424/acst-20230330.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000095017023011424/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000095017023011424/acst-20230330.htm

Filed Mar 31, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-011424. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.